Skip to content

How Easy-to-Follow Exercises Can Help Cancer Patients With Anxiety While Receiving Chemotherapy

The Effect of Mild Exercise While Receiving Chemotherapy on the Psychology of the Cancer Patient

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06943638
Enrollment
45
Registered
2025-04-24
Start date
2024-12-02
Completion date
2025-03-24
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Exercise, Stress

Keywords

cancer, physiotherapy, exercise, physical therapy, chemotherapy, stress

Brief summary

Cancer is one of the main causes of death, and this study looks at how light exercise and stretching might reduce anxiety in patients receiving chemotherapy. The research took place in a hospital's daily care unit and used a study design where each patient was compared to themselves, measuring anxiety before and after the exercise program.

Interventions

OTHERMild Exercise and stretches

For 15 minutes the patient received an individualized mild workout program intending to relax and relieve some of his stress. The workout includes deep breaths, easy-to-do exercises, and stretches from lying on the bed, sitting in a chair, or standing. I always followed the patient's tempo and provided him with as many breaks as he needed.

Sponsors

Christine Mavrogiannopoulou
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (\>18 years old) with cancer receiving chemotherapy * Signed patient consent

Exclusion criteria

* The denial of the patient * The occurrence of side effects from the treatment (such as dizziness, nausea, severe fatigue) * Patients with low cognitive level where they could not follow simple instructions * Patients with hearing disorders that prevented them from following simple instructions * Patients who could not mobilize independently.

Design outcomes

Primary

MeasureTime frameDescription
The Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and StretchesBaseline and approximately 20 minutes post-interventionThe STAI-State (Greek version, State-Trait Anxiety Inventory -STAI-) will be used to assess anxiety levels in cancer patients undergoing chemotherapy, before and after a brief exercise intervention. The STAI-State scale has a 20-item questionnaire where individuals rate how they feel at a particular moment on a scale from not at all to very much so. Not at all equal to 1, Somewhat to 2, Moderately so to 3, Very much so to 4. Scores are submitted and range from 20 to 80, with higher scores indicating greater anxiety. No subscale is required to compute At baseline (Time = 0 minutes), participants complete the STAI-State scale. They then engage in a 15-minute mild exercise and stretching program tailored to their physical condition. In some cases, particularly among younger participants, the session may be conducted in small groups of up to 2 individuals. Immediately post-intervention (approximately 20 minutes from baseline), participants complete the STAI-State scale again.

Countries

Greece

Participant flow

Recruitment details

Participants were recruited from the General Oncology Hospital of Kifissia Agioi Anargyroi in Athens, Greece. Eligible patients undergoing chemotherapy were invited to participate during routine clinical visits. Written informed consent was obtained from all participants.

Pre-assignment details

There are no pre-assignement details

Participants by arm

ArmCount
Mild Exercise and Stretching
They received individualized workout and stretching programme to relieve some of the stress
45
Total45

Baseline characteristics

CharacteristicMild Exercise and Stretching
Age, Continuous68.5 Years
STANDARD_DEVIATION 8.5
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Greece
45 Participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
25 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 45
other
Total, other adverse events
0 / 45
serious
Total, serious adverse events
0 / 45

Outcome results

Primary

The Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and Stretches

The STAI-State (Greek version, State-Trait Anxiety Inventory -STAI-) will be used to assess anxiety levels in cancer patients undergoing chemotherapy, before and after a brief exercise intervention. The STAI-State scale has a 20-item questionnaire where individuals rate how they feel at a particular moment on a scale from not at all to very much so. Not at all equal to 1, Somewhat to 2, Moderately so to 3, Very much so to 4. Scores are submitted and range from 20 to 80, with higher scores indicating greater anxiety. No subscale is required to compute At baseline (Time = 0 minutes), participants complete the STAI-State scale. They then engage in a 15-minute mild exercise and stretching program tailored to their physical condition. In some cases, particularly among younger participants, the session may be conducted in small groups of up to 2 individuals. Immediately post-intervention (approximately 20 minutes from baseline), participants complete the STAI-State scale again.

Time frame: Baseline and approximately 20 minutes post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
Mild Exercise and StretchingThe Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and StretchesPre- intervention37.73 STAI-State scoreStandard Deviation 13.33
Mild Exercise and StretchingThe Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and StretchesPost- intervention32 STAI-State scoreStandard Deviation 14.22
p-value: <0.0001Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026